278 related articles for article (PubMed ID: 23284172)
1. RAC1P29S is a spontaneously activating cancer-associated GTPase.
Davis MJ; Ha BH; Holman EC; Halaban R; Schlessinger J; Boggon TJ
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):912-7. PubMed ID: 23284172
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Differences of Activation of Rac1
Senyuz S; Jang H; Nussinov R; Keskin O; Gursoy A
J Phys Chem B; 2021 Apr; 125(15):3790-3802. PubMed ID: 33848152
[TBL] [Abstract][Full Text] [Related]
3. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
4. DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1
Tomino T; Tajiri H; Tatsuguchi T; Shirai T; Oisaki K; Matsunaga S; Sanematsu F; Sakata D; Yoshizumi T; Maehara Y; Kanai M; Cote JF; Fukui Y; Uruno T
Biochem Biophys Res Commun; 2018 Feb; 497(1):298-304. PubMed ID: 29432733
[TBL] [Abstract][Full Text] [Related]
5. Conformational landscape alternations promote oncogenic activities of Ras-related C3 botulinum toxin substrate 1 as revealed by NMR.
Toyama Y; Kontani K; Katada T; Shimada I
Sci Adv; 2019 Mar; 5(3):eaav8945. PubMed ID: 30891502
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
[TBL] [Abstract][Full Text] [Related]
7. The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling.
Masuda-Robens JM; Kutney SN; Qi H; Chou MM
Mol Cell Biol; 2003 Mar; 23(6):2151-61. PubMed ID: 12612085
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase.
Fiegen D; Haeusler LC; Blumenstein L; Herbrand U; Dvorsky R; Vetter IR; Ahmadian MR
J Biol Chem; 2004 Feb; 279(6):4743-9. PubMed ID: 14625275
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for Rac1 recognition by guanine nucleotide exchange factors.
Karnoub AE; Worthylake DK; Rossman KL; Pruitt WM; Campbell SL; Sondek J; Der CJ
Nat Struct Biol; 2001 Dec; 8(12):1037-41. PubMed ID: 11685227
[TBL] [Abstract][Full Text] [Related]
10. RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.
Foth M; Parkman G; Battistone B; McMahon M
Pigment Cell Melanoma Res; 2020 Sep; 33(5):719-730. PubMed ID: 32406574
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of fast-cycling RhoF GTPase.
Sugawara R; Ueda H; Honda R
Biochem Biophys Res Commun; 2019 May; 513(2):522-527. PubMed ID: 30981505
[TBL] [Abstract][Full Text] [Related]
12. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins.
Zhang B; Zhang Y; Wang Z; Zheng Y
J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989
[TBL] [Abstract][Full Text] [Related]
13. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
Mar VJ; Wong SQ; Logan A; Nguyen T; Cebon J; Kelly JW; Wolfe R; Dobrovic A; McLean C; McArthur GA
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1117-25. PubMed ID: 25043693
[TBL] [Abstract][Full Text] [Related]
15. RAC1
Lionarons DA; Hancock DC; Rana S; East P; Moore C; Murillo MM; Carvalho J; Spencer-Dene B; Herbert E; Stamp G; Damry D; Calado DP; Rosewell I; Fritsch R; Neubig RR; Molina-Arcas M; Downward J
Cancer Cell; 2019 Jul; 36(1):68-83.e9. PubMed ID: 31257073
[TBL] [Abstract][Full Text] [Related]
16. RAC1 and melanoma.
Halaban R
Clin Ther; 2015 Mar; 37(3):682-5. PubMed ID: 25465943
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.
Acuner SE; Sumbul F; Torun H; Haliloglu T
Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600
[TBL] [Abstract][Full Text] [Related]
18. The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.
Watson IR; Li L; Cabeceiras PK; Mahdavi M; Gutschner T; Genovese G; Wang G; Fang Z; Tepper JM; Stemke-Hale K; Tsai KY; Davies MA; Mills GB; Chin L
Cancer Res; 2014 Sep; 74(17):4845-4852. PubMed ID: 25056119
[TBL] [Abstract][Full Text] [Related]
19. RAC1 P29S regulates PD-L1 expression in melanoma.
Vu HL; Rosenbaum S; Purwin TJ; Davies MA; Aplin AE
Pigment Cell Melanoma Res; 2015 Sep; 28(5):590-8. PubMed ID: 26176707
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex.
Di-Poï N; Fauré J; Grizot S; Molnár G; Pick E; Dagher MC
Biochemistry; 2001 Aug; 40(34):10014-22. PubMed ID: 11513579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]